Elutability of proteins from aluminum-containing vaccine adjuvants by treatment with surfactants

被引:31
|
作者
Rinella, JV
Workman, RF
Hermodson, MA
White, JL
Hem, SL [1 ]
机构
[1] Purdue Univ, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA
[2] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA
[3] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA
[4] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA
关键词
elutability; aluminum hydroxide adjuvant; aluminum phosphate adjuvant; surfactant-induced elution; desorption of preadsorbed proteins; solubilization; micellar solubilization; electrostatic repulsion;
D O I
10.1006/jcis.1997.5230
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The elutability of proteins from adjuvants in model vaccines composed of ovalbumin adsorbed by aluminum hydroxide adjuvant or lysozyme adsorbed by aluminum phosphate adjuvant following treatment with surfactant solutions was studied. Nonionic (Triton X-100, lauryl maltoside), zwitterionic (lauryl sulfobetaine), anionic (sodium dodecyl sulfate), and cationic (cetylpyridinium chloride, dodecyltrimethylammonium chloride) surfactants were investigated. Cetylpyridinium chloride produced the greatest degree of elution (60%) of ovalbumin from aluminum hydroxide adjuvant. Sodium dodecyl sulfate completely eluted lysozyme from aluminum phosphate adjuvant. The effectiveness of surfactants in removing preadsorbed proteins was directly related to their ability to denature the protein. Micellar solubilization and electrostatic repulsion may also contribute to desorption. (C) 1998 Academic Press.
引用
收藏
页码:48 / 56
页数:9
相关论文
共 50 条
  • [21] Effect of phosphorylation of ovalbumin on adsorption by aluminum-containing adjuvants and elution upon exposure to interstitial fluid
    Morefield, GL
    Jiang, DP
    Romero-Mendez, IZ
    Geahlen, RL
    HogenEsch, H
    Hem, SL
    VACCINE, 2005, 23 (12) : 1502 - 1506
  • [23] Refining of Aluminum-Containing Chloride Solutions from Iron
    A. P. Lysenko
    E. S. Kondrat’eva
    Russian Metallurgy (Metally), 2021, 2021 : 1544 - 1549
  • [24] Aluminum-containing vaccine associated adverse events: role of route of administration and gender
    Pittman, PR
    VACCINE, 2002, 20 : S48 - S50
  • [25] Refining of Aluminum-Containing Chloride Solutions from Iron
    Lysenko, A. P.
    Kondrat'eva, E. S.
    RUSSIAN METALLURGY, 2021, 2021 (12): : 1544 - 1549
  • [26] Activation of dendritic cells and induction of CD4+ T cell differentiation by aluminum-containing adjuvants
    Sokolovska, Anna
    Hem, Stanley L.
    HogenEsch, Harm
    VACCINE, 2007, 25 (23) : 4575 - 4585
  • [27] Development of a High-Throughput Screening Platform to Study the Adsorption of Antigens onto Aluminum-Containing Adjuvants
    Jully, Vanessa
    Moniotte, Nicolas
    Mathot, Frederic
    Lemoine, Dominique
    Preat, Veronique
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 104 (02) : 557 - 565
  • [28] Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response
    Noe, Stephanie M.
    Green, Mark A.
    HogenEsch, Harm
    Hem, Stanley L.
    VACCINE, 2010, 28 (20) : 3588 - 3594
  • [29] Characterization of silica-pillared derivatives from aluminum-containing kanemite
    Toriya, S
    Takei, T
    Fuji, M
    Chikazawa, M
    JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2003, 268 (02) : 435 - 440
  • [30] Patterns of binding of aluminum-containing adjuvants to Haemophilus influenzae type b and meningococcal group C conjugate vaccines and components
    Otto, Robert B. D.
    Burkin, Karena
    Amir, Saba Erum
    Crane, Dennis T.
    Bolgiano, Barbara
    BIOLOGICALS, 2015, 43 (05) : 355 - 362